Surprisingly, these patients carried dominant negative heterozygous mutations in ATAD3A, encoding the mitochondrial AAA ATPase protein ATAD3A, previously described to cause mitochondrial disease with neurological features (84, 85). The gene discussed is ATAD3A; the disease is inborn mitochondrial metabolism disorder.